By Steph Seidel
Individuals with the Wood Buffalo Food Bank collecting food donations // Photo via WB Food Bank
The Wood Buffalo Food Bank will be hosting their Spring Food Drive after all.
While it’s usually held in April; the COVID-19 pandemic has changed up the plans.
This year, the drive will come to residents with those wishing to donate registering their address online.
Those who donate will be given a date for their donation to be placed outside their door before 9:00 am. on either June 11, 12, or 13.
On June 11, Food Bank employees will go to addresses in Stonecreek, Timberlea, Eagle Ridge, Parsons Creek, and Dickensfield.
HOUSTON, May 27, 2021 (GLOBE NEWSWIRE)
Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share on the Company’s common stock, payable June 30, 2021, to shareholders of record on June 15, 2021.
About Quanex
Quanex Building Products Corporation is an industry-leading manufacturer of components sold to Original Equipment Manufacturers (OEMs) in the building products industry. Quanex designs and produces energy-efficient fenestration products in addition to kitchen and bath cabinet components.
Contact:
Message :
Required fields
NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported significantly improved quality of life and work productivity after transitioning from long-acting injectable somatostatin analogs (iSSAs) to MYCAPSSA
®. The data were shared as an oral presentation at the 30
th Annual American Association of Clinical Endocrinology (AACE) Meeting being held virtually from May 26-29, 2021.
“The encouraging PROs data from the MPOWERED study further our understanding of the potential positive clinical impact that MYCAPSSA has for patients with acromegaly,” said Nienke Biermasz, M.D., Ph.D., Presenting Author. “These PROs provide important information to help physicians assess disease and treatment burden for patients treated with iSSAs and may provide the c